Mode
Text Size
Log in / Sign up
N/A N=185 Diagnostic

Study Utilizing BIOZEK COVID-19 Antigen Rapid Test

Covid-19 Testing

Enrolled (actual)
185
Serious AEs
0.0%
Results posted
Dec 2023
Primary outcome: Primary: Sensitivity and Specificity of Biozek Covid-19 Antigen Rapid Test (Saliva) — 97.5; 100 percentage - Sensitivity and specificity

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Biozek Covid-19 Antigen Rapid Test (Saliva) (Diagnostic_test)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Mach-E B.V.
Primary completion
Nov 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Sensitivity and Specificity of Biozek Covid-19 Antigen Rapid Test (Saliva)
97.5; 100
PRIMARY
Sensitivity and Specificity of Biozek Covid-19 Antigen Rapid Test (Nasopharyngeal Swab)
97.8; 100

Summary

This is a research study to evaluate the Sensitivity and Specificity of BIOZEK COVID-19 Antigen Rapid Test (Saliva) and BIOZEK COVID-19 Antigen Rapid Test (Nasopharyngeal Swab) on samples that are self-collected; and to perform analysis to compare results. In addition, to obtain RT-PCR test results, performed prior to enrollment, and compare all three results.

Eligibility Criteria

Inclusion Criteria

  • Subjects must be ≥18 years of age and have had an RT-PCR test performed prior to enrollment.
  • Subjects must be able to understand and willingly sign a written informed consent. Additionally, participants need to meet at least 1 of the criteria listed below:
  • Currently experiencing symptoms of COVID-19.
  • Be clinically diagnosed or suspected to have COVID-19.
  • Recent past (3 weeks) exhibited symptoms of COVID-19.
  • Be capable of performing a self-collection of a nasopharyngeal sample with use of nasal swab kit.
  • Be capable of performing a self-collection of an oral fluid sample with use of oral fluid collection kit.
  • Interacted with a COVID-19 positive individual.

Exclusion Criteria

Subjects who meet any of the following exclusion criteria may not be enrolled in this study:

  • Cannot perform self-collection of a nasopharyngeal sample with use of nasal swab kit.
  • Cannot perform self-collection of an oral fluid sample with use of oral fluid collection kit.
  • Have a deviated nasal septum.
  • Cognitively impaired individuals resulting in the inability to provide informed consent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04926779). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search